Company Registration No. 08226415 (England and Wales)
Alpharma Limited
Unaudited accounts
for the year ended 30 November 2022
Alpharma Limited
Unaudited accounts
Contents
Alpharma Limited
Company Information
for the year ended 30 November 2022
Company Number
08226415 (England and Wales)
Registered Office
195-197 OTLEY ROAD
BRADFORD
WEST YORKSHIRE
BD3 0JF
Alpharma Limited
Statement of financial position
as at 30 November 2022
Tangible assets
4,213
4,350
Cash at bank and in hand
1,705
4,890
Creditors: amounts falling due within one year
(55,313)
(83,372)
Net current liabilities
(2,073)
(2,922)
Called up share capital
150
150
Profit and loss account
1,990
1,278
Shareholders' funds
2,140
1,428
For the year ending 30 November 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 30 May 2023 and were signed on its behalf by
M Issat
Director
Company Registration No. 08226415
Alpharma Limited
Notes to the Accounts
for the year ended 30 November 2022
Alpharma Limited is a private company, limited by shares, registered in England and Wales, registration number 08226415. The registered office is 195-197 OTLEY ROAD, BRADFORD, WEST YORKSHIRE, BD3 0JF.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
20% reducing balance
Computer equipment
50% straight line
4
Tangible fixed assets
Plant & machinery
Computer equipment
Total
Cost or valuation
At cost
At cost
At 1 December 2021
7,285
11,226
18,511
At 30 November 2022
8,201
11,226
19,427
At 1 December 2021
2,935
11,226
14,161
Charge for the year
1,053
-
1,053
At 30 November 2022
3,988
11,226
15,214
At 30 November 2022
4,213
-
4,213
At 30 November 2021
4,350
-
4,350
Alpharma Limited
Notes to the Accounts
for the year ended 30 November 2022
Amounts falling due within one year
Trade debtors
2,535
26,560
Other debtors
49,000
49,000
6
Creditors: amounts falling due within one year
2022
2021
Bank loans and overdrafts
35,000
35,000
Trade creditors
12,424
24,328
Taxes and social security
6,425
2,366
Loans from directors
29
18,943
7
Average number of employees
During the year the average number of employees was 3 (2021: 3).
